Market Capitalization | 1.2M |
Book Value | $3.27 |
Earnings Per Share (EPS) | -4.37 |
Wall Street Target Price | 18.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -48.31% |
Return On Equity TTM | -83.97% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -13.0M |
Diluted Eps TTM | -4.37 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. | -2.2% | 20.15% | 39.88% | 76.57% | 303.42% |
Novo Nordisk A/s | 1.56% | 3.09% | 46.83% | 167.63% | 453.76% |
Alnylam Pharmaceuticals, Inc. | -1.11% | 79.95% | 47.56% | 39.47% | 212.93% |
Vertex Pharmaceuticals Incorporated | 1.68% | 17.99% | 37.89% | 159.42% | 173.37% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. | 30.86 | 30.86 | 1.59 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 46.01 | 46.01 | 2.08 | 3.41 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.55 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.59 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. | Buy | $128.4B | 303.42% | 30.86 | 32.04% |
Novo Nordisk A/s | Buy | $600.4B | 453.76% | 46.01 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $34.1B | 212.93% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $125.3B | 173.37% | 32.84 | -4.74% |
Insights on CWBR
In the last 1 year, Novo Nordisk A/s has given 43.9% return, outperforming this stock by 129.6%
In the last 3 years, Novo Nordisk A/s has given 167.6% return, outperforming this stock by 266.3%
Keyarch Acquisition Corp
$0.43
+0.0%
Connexa Sports Technologies Inc
$0.43
+0.0%
Us Value Etf
$0.43
+0.0%
First Wave Biopharma Inc
$0.43
+0.0%
Global X Msci Next Emerging
$0.43
+0.0%
Fat Projects Acquisition Corp
$0.43
+0.0%
Capital Link Global Fintech
$0.43
+0.0%
Applied Uv Inc
$0.43
+0.0%
Columbia International Esg Equity Income Etf
$0.43
+0.0%